Reminder to Register for GC Collab Access
Health Canada Posted Good Manufacturing Practices for Active Pharmaceutical Ingredients (GUI-0104)
DEL Bulletin LEPP No.127: Updates to the Generic Email Accounts and Contact Information
Webinars Series on the Environmental Emergency Regulations, 2019
Stakeholder Survey on Health Canada Programs
Annual Cost Recovery Stakeholder Meeting
RPRA Consulting on Simplified Steward Fee-setting Methodology for Blue Box Program Transition Period
RPRA appoints Mary Cummins as Registrar
Updates to the Drug Establishment License (DEL) Application Form & Process
Notice of intent — Consultation on Modernizing the Medical Device and Drug Establishment Licensing Frameworks (Phase I)
